Anixa Biosciences (ANIX) Insider buying
27 open-market purchases of ANIX by Anixa Biosciences's executives and directors since June 2025, worth $660,972 in total, from SEC Form 4 filings.
Summary
The most recent: Amit Kumar, Chief Executive Officer bought $15,850 on October 30, 2026.
The biggest buyer over the period is Lewis H Titterton Jr (Director): 8 purchases, $303,548.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 21 | $521,772 |
| 2025 | 6 | $139,200 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Lewis H Titterton Jr Director | 8 | $303,548 |
| Amit Kumar Chief Executive Officer | 15 | $280,654 |
| Arnold M Baskies Director | 3 | $61,150 |
| Michael Catelani President, COO, & CFO | 1 | $15,620 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Oct 30, 2026 | Kumar Amit Chief Executive Officer |
5,000 | $3.17 | $15,850 | Form 4 |
| Oct 23, 2026 | H Titterton Lewis Jr Director |
8,000 | $2.98 | $23,840 | Form 4 |
| Oct 22, 2026 | Kumar Amit Chief Executive Officer |
8,000 | $2.72 | $21,760 | Form 4 |
| Sep 30, 2026 | Catelani Michael President, COO, & CFO |
5,500 | $2.84 | $15,620 | Form 4 |
| Sep 24, 2026 | Kumar Amit Chief Executive Officer |
7,000 | $2.78 | $19,460 | Form 4 |
| Sep 24, 2026 | M Baskies Arnold Director |
5,000 | $2.76 | $13,800 | Form 4 |
| Sep 23, 2026 | H Titterton Lewis Jr Director |
49,036 | $2.69 | $131,907 | Form 4 |
| Sep 10, 2026 | Kumar Amit Chief Executive Officer |
5,000 | $2.76 | $13,800 | Form 4 |
| Sep 10, 2026 | H Titterton Lewis Jr Director |
10,000 | $2.73 | $27,300 | Form 4 |
| Sep 10, 2026 | Kumar Amit Chief Executive Officer |
3,000 | $2.75 | $8,250 | Form 4 |
| Jul 31, 2026 | Kumar Amit Chief Executive Officer |
5,000 | $3.47 | $17,350 | Form 4 |
| Jul 27, 2026 | Kumar Amit Chief Executive Officer |
5,000 | $3.44 | $17,200 | Form 4 |
| Jul 27, 2026 | Kumar Amit Chief Executive Officer |
3,188 | $3.37 | $10,744 | Form 4 |
| Jul 24, 2026 | Kumar Amit Chief Executive Officer |
3,000 | $3.73 | $11,190 | Form 4 |
| Jul 20, 2026 | Kumar Amit Chief Executive Officer |
5,000 | $3.46 | $17,300 | Form 4 |
| Jul 20, 2026 | H Titterton Lewis Jr Director |
12,000 | $3.47 | $41,640 | Form 4 |
| Jul 15, 2026 | H Titterton Lewis Jr Director |
2,797 | $3.28 | $9,174 | Form 4 |
| Jul 10, 2026 | Kumar Amit Chief Executive Officer |
5,000 | $3.04 | $15,200 | Form 4 |
| Jun 16, 2026 | H Titterton Lewis Jr Director |
2,836 | $2.64 | $7,487 | Form 4 |
| Jun 12, 2026 | Kumar Amit Chief Executive Officer |
21,000 | $2.50 | $52,500 | Form 4 |
| Jan 28, 2026 | M Baskies Arnold |
10,000 | $3.04 | $30,400 | Form 4 |
| Jul 31, 2025 | H Titterton Lewis Jr |
10,000 | $3.08 | $30,800 | Form 4 |
| Jul 30, 2025 | Kumar Amit |
5,000 | $3.16 | $15,800 | Form 4 |
| Jul 18, 2025 | M Baskies Arnold |
5,000 | $3.39 | $16,950 | Form 4 |
| Jul 11, 2025 | Kumar Amit |
5,000 | $3.15 | $15,750 | Form 4 |
| Jul 11, 2025 | H Titterton Lewis Jr |
10,000 | $3.14 | $31,400 | Form 4 |
| Jun 4, 2025 | Kumar Amit |
10,000 | $2.85 | $28,500 | Form 4 |
Questions about Anixa Biosciences
Are Anixa Biosciences insiders buying the stock?
27 open-market purchases of ANIX by Anixa Biosciences's executives and directors since June 2025, worth $660,972 in total, from SEC Form 4 filings. The most recent: Amit Kumar, Chief Executive Officer bought $15,850 on October 30, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Anixa Biosciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.